Refine Search

New Search

Results in Journal Open Access Journal of Oncology and Medicine: 87

(searched for: journal_id:(4148104))
Page of 2
Articles per Page
by
Show export options
  Select all
Barbara Köditz, Andreas Stog, Manuel Huerat Arana, Jochen Wu Fries, Melanie von Brandenstein, Axel Heidenreich
Open Access Journal of Oncology and Medicine, Volume 4, pp 402-408; https://doi.org/10.32474/oajom.2021.04.000189

James Wheeler
Open Access Journal of Oncology and Medicine, Volume 4, pp 400-401; https://doi.org/10.32474/oajom.2021.04.000188

Marconcini Riccardo, Nuzzo Amedeo, Manacorda Simona, Falcone Alfredo, De Rosa Francesco, Palla Marco, Fava Paolo, Di Guardo Lorenza Alessia, Tucci Marco, Todisco Annalisa, et al.
Open Access Journal of Oncology and Medicine, Volume 4, pp 392-399; https://doi.org/10.32474/oajom.2021.04.000187

Stefano Siringo, Fortunato Genovese, Vito Leanza, Marco Palumbo, Attilio Tuscano, Francesco Cannone, Francesco Cosentino
Open Access Journal of Oncology and Medicine, Volume 4, pp 369-379; https://doi.org/10.32474/oajom.2020.04.000184

Wei Chen, Guoping Sun, Victoria J Wang, Zhibin Zhang, Ruizhen Xu, Jinjun Qiu, Shi V Liu
Open Access Journal of Oncology and Medicine, Volume 4, pp 365-368; https://doi.org/10.32474/oajom.2020.04.000183

Detlef K Bartsch, Elvira Matthäi, Ioannis Mintziras, Lutz Benedikt Böhm, Norman Gercke, Christian Bauer, Jens Figiel, Emily P Slater
Open Access Journal of Oncology and Medicine, Volume 4, pp 339-346; https://doi.org/10.32474/oajom.2020.04.000178

Reena Engineer, Shwetabh Sinha, Supriya Chopra, Vikas Ostwal, Anant Ramaswamy, Nitin Shetty
Open Access Journal of Oncology and Medicine, Volume 4, pp 333-338; https://doi.org/10.32474/oajom.2020.04.000177

Aymen Abdeljilil
Open Access Journal of Oncology and Medicine, Volume 4, pp 329-332; https://doi.org/10.32474/oajom.2020.04.000176

Mohammed J Alyousef, Mohammed M Hajla, Maha Abdel Hadi
Open Access Journal of Oncology and Medicine, Volume 3, pp 325-328; https://doi.org/10.32474/oajom.2020.03.000175

Huda Alsayedahmed, Nafeesa Alfaris, Adil AlKhatti, Samer Abushullaih, Fuad Alghamdi, Joshua Sharp, Raed Alsharraya, Salam Abughaida, Issam Abduljaber, Dalal AlMuhaisen
Open Access Journal of Oncology and Medicine, Volume 3, pp 318-324; https://doi.org/10.32474/oajom.2020.03.000174

Wael Ferjaoui, Dhouha Bacha, Lasaad Gharbi, Ghofrane Talbi, Sahir Omrani, Bouraoui Saadia
Open Access Journal of Oncology and Medicine, Volume 3, pp 292-294; https://doi.org/10.32474/oajom.2020.03.000168

Pedro Henrique Ferro De Brito, Eliane Portela Nogueira, Osvaldo Antonio Prado Castro, Lucas Motta Ganem, Daniel Kendi Fukuhara, Roberto De Moraes Cordts, Mariana De Souza Marinho, Laura Carolina Lopez Claro, Wilson Freitas Junior, Fabio Rodrigues Thuler, et al.
Open Access Journal of Oncology and Medicine, Volume 3, pp 284-288; https://doi.org/10.32474/oajom.2020.03.000166

Tina W Wong, Debra A Wong, Hashem Ayyad, David Row, Ronald A Gagliano, James Mankin
Open Access Journal of Oncology and Medicine, Volume 3, pp 269-275; https://doi.org/10.32474/oajom.2020.03.000164

Shah Murad, Adnan Shafique, Amarlal Ghurbakhshani, Seema Shah Murad, Abdul Ghaffar, Jamila Shah
Open Access Journal of Oncology and Medicine, Volume 3, pp 265-268; https://doi.org/10.32474/oajom.2020.03.000163

Julius Gene Latorre, Dani Choufani, Elena Schmidt, Gurmeet Singh Sarla
Open Access Journal of Oncology and Medicine, Volume 3, pp 256-259; https://doi.org/10.32474/oajom.2019.03.000160

Obeagu Emmanuel Ifeanyi, Okorie Hope M, Obeagu Getrude Uzoma, Anaebo Queen Braxton N
Open Access Journal of Oncology and Medicine, Volume 3, pp 250-252; https://doi.org/10.32474/oajom.2019.03.000158

Gurmeet Singh Sarla
Open Access Journal of Oncology and Medicine, Volume 3, pp 253-255; https://doi.org/10.32474/oajom.2019.03.000159

Fatemeh Khatami, Seyed Mohammad Kazem Aghamir, Maryam Aghaii
Open Access Journal of Oncology and Medicine, Volume 3, pp 246-247; https://doi.org/10.32474/oajom.2019.03.000156

Richard M Fleming, Matthew R Fleming, Tapan K Chaudhuri, William C Dooley
Open Access Journal of Oncology and Medicine, Volume 3, pp 248-249; https://doi.org/10.32474/oajom.2019.03.000157

Richard M Fleming, Matthew R Fleming, Tapan K Chaudhuri, Andrew McKusick, William C Dooley
Open Access Journal of Oncology and Medicine, Volume 3, pp 238-239; https://doi.org/10.32474/oajom.2019.03.000154

Richard M Fleming, Matthew R Fleming, Andrew McKusick, Tapan K Chaudhuri
Open Access Journal of Oncology and Medicine, Volume 3, pp 233-237; https://doi.org/10.32474/oajom.2019.03.000153

Surya Prakash Gautam, Bhupinder Kaur, Tapsya Gautam
Open Access Journal of Oncology and Medicine, Volume 3, pp 230-232; https://doi.org/10.32474/oajom.2019.03.000152

Cherian Verghese, Xiaojin Sha, Talal Khan, Emmanouil Alimpertis, Hany Meawad, Riddhish Sheth, Feraz Khogeer, Anis Toumeh, Nauman Siddiqui, Robert Booth
Open Access Journal of Oncology and Medicine, Volume 2, pp 215-218; https://doi.org/10.32474/oajom.2019.02.000149

Lara Abdelmunim I Abdelrahman, Mohamed E Gar Elanabi, Nahla Gafer
Open Access Journal of Oncology and Medicine, Volume 2, pp 1-8; https://doi.org/10.32474/oajom.2019.02.000147

Abstract:
Metastatic breast cancer (MBC) is incurable, but still treatable, especially if there are limited metastases. The intent of treatment is palliative, providing symptomatic relief and optimization of the length and quality of life.
Victoria Aginova
Open Access Journal of Oncology and Medicine, Volume 2, pp 1-3; https://doi.org/10.32474/oajom.2019.02.000146

Abstract:
The emergence and spread of carbapenem-resistant (CarR) bacteria are a global problem for treatment of patients all over the world. This type of antimicrobial resistant is particularly danger by cancer patients. Regular monitoring of carbapenem-resistant microorganisms and the determination of the mechanism of their spread will help keep CarR bacteria from spreading This article contains the results of monitoring of carbapenem-resistant strains of microorganisms in the oncological clinic.
Tayyaba Saher
Open Access Journal of Oncology and Medicine, Volume 2, pp 1-3; https://doi.org/10.32474/oajom.2018.02.000145

Abstract:
The present study was objected to check the awareness about SARS among scholars of university. The pupil of Bahauddin Zakariya university Multan acted as the subjects for this research. Total of 109 subjects showed consent to be the part of this study. Severe acute respiratory syndrome (SARS) is considered a deadly animal virus which, perhaps originated from bats and then it was spread to other animals. According to a report, the humans were affected by SARS very firstly in 2002 in Guangdong, china. a report by World health organization states that 8098 people were affected by SARS in an outbreak during 2003, out of which 774 died. It was first observed as an influenza like disease with headache, fever leading to failure of respiratory system and sometimes death of the patient. The early symptoms of SARS are headache, body ache, high fever, coughing and sneezing, feeling difficulty in breathing leading to asthma sometimes. Treatment of SARS includes taking antibiotics (to prevent pneumonia) and some antiviral medicines. Present research helped in knowing about the knowledge of SARS in university students. This study helped in estimating that 84.40% pupil consider SARS as a viral disease, 12.84% students think it’s a genetic problem while 9.17% suppose it’s a metabolic error.
Rüdiger Hardeland
Open Access Journal of Oncology and Medicine, Volume 2, pp 1-4; https://doi.org/10.32474/oajom.2018.02.000144

Abstract:
The release of exosomes and ectosomes carrying noncoding RNAs is addressed in the context of cancer, with focus on microRNAs and long noncoding RNAs as well as differences in RNA cargos produced by tumor and nontumor cells. The differential appearance of ncRNAs can be used for diagnostic and prognostic purposes. Beyond these possibilities, the spreading of pathological and beneficial messages deserves particular attention and will gain future importance. Especially the use of exosomes released by cells that overexpress ncRNAs with antitumor properties appears to be a promising strategy.
Misra Jata Shankar, Srivastava Anand Narain, Kunwar Shipra, Fatima Naseem, Khan Mohshin Ali
Open Access Journal of Oncology and Medicine, Volume 2, pp 1-3; https://doi.org/10.32474/oajom.2018.02.000143

Abstract:
Carcinoma cervix is a major health problem faced by Indian women and though its incidence has declined in urban population in recent years but in the rural India where 70% of the people dwell, cervical cancer still remains on top [1]. It is mainly due to illiteracy and ignorance about the factors contributing to the development of cervical cancer. The rural women are mostly poor and backward, have poor genital hygiene and are not aware of major risk factors like marriage at an early age and multiparity [2]. Therefore, creating awareness about the hazards of cervical cancer and apprising them regarding the importance of early detection of the disease and associated risk factors are the need of the hour [3,4]..
Bakulesh Khamar
Open Access Journal of Oncology and Medicine, Volume 2, pp 1-6; https://doi.org/10.32474/oajom.2018.02.000140

Abstract:
Checkpoint inhibitors have demonstrated efficacy in squamous NSCLC with tolerable toxicity profile. They are used as a monotherapy, in combination with chemotherapy or following chemo-radiotherapy as a first line, second line or consolidation therapy. As a first line, Pembrolizumab improves outcome (PFS) as a monotherapy in patients with PD-L1 expression of ≥ 50% (HR; 0.35). When used with chemotherapy, it improves PFS (HR; 0.56) irrespective of PD-L1 expression level. Nivolumab also improves PFS (HR; 0.62), when used as a second line for those progressing with chemotherapy. Durvalumab improves PFS (HR; 0.68) when used following chemo-radio therapy as a consolidation therapy.
Lale Olcay, Ceren Kılcı, Taner Sezer, I Zafer Ecevit, Murat Özkan, Birgül Varan
Open Access Journal of Oncology and Medicine, Volume 2, pp 1-16; https://doi.org/10.32474/oajom.2018.02.000139

Page of 2
Articles per Page
by
Show export options
  Select all
Back to Top Top